Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-06-07
2005-06-07
Wax, Robert A. (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S016700, C514S017400, C530S311000, C530S321000, C530S328000
Reexamination Certificate
active
06903074
ABSTRACT:
A novel class of analogs which exhibit both high affinity and selectivity for Neuromedin B and Somatostann receptors are claimed. One example is Nal-Tyr-cyclo(D-Cys-D-Trp-Lys-D-Cys)-Abu-Nal-NH2.
REFERENCES:
patent: 5462926 (1995-10-01), Coy et al.
patent: 0 127 899 (1984-06-01), None
patent: 0 395 417 (1990-04-01), None
patent: 0 395 417 (1990-04-01), None
patent: 0 478 101 (1991-09-01), None
patent: 1 033 372 (1998-11-01), None
patent: WO 99/25729 (1999-05-01), None
patent: WO 84/04916 (1984-12-01), None
patent: WO 93/03056 (1993-02-01), None
patent: WO 94/05310 (1994-03-01), None
patent: WO 97/11962 (1997-04-01), None
patent: WO 98/51332 (1998-11-01), None
David H. Coy, et al., “Somatostatin receptor antagonists based on a mixed neuromedin B antagonist/somatostatin agonist” Pept. Proc. Am. Pept. Symp., 15th (1999), pp. 526-529, XP000917964.
Richard R. Ryan et al., “Comparative Pharmacology of the Nonpeptide Neuromedin B Receptor Antagonist PD 168368” J. Pharmacol. Exp Ther. (1999), pp. 1202-1211, XP000917708.
Akira Kubota et al., “Effector Coupling of Somatostatin Receptor Subtypes on Human Endocrine Tumors”, Metabolism Clinical and Experimental, (1996), vol. 45, no 8 Suppl. 1, pp. 42-45 XP002149617.
A. Horvàth et al., “Somatostatin Octa- and Heptapeptides, Structural and Biological Characteristics”, Pept. (1998), Proc. Eur. Pept. Symp, pp. 483-484, XP000918406.
Morgan Barry A.
Sadat-Aalaee Dean
Feeney Alan F.
Fish & Richardson
Morrill Brian R.
Societe de Conseils de Recherches et d'Applications Scientifique
Wax Robert A.
LandOfFree
Neuromedin b and somatostatin receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neuromedin b and somatostatin receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuromedin b and somatostatin receptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3504803